Agree with the other CDX posters - this was a good update, and probably expected now that the EGM was out of the way
Key take aways for me were:
Cardiex pharma sales continue to be strong - with May 2024 the best month in the last six months & June always a strong month.
Production units of Pulse expected in early July (few weeks away).
3,000 x Pulse units expected in Q1 FY25.
Chip inventory for Pulse = 30,000
Created a Pulse wait list on the (new) website - on current trends, anticipated to have over 20,000 on this wait list by the time they start taking orders of the Pulse.
This wait list has been created from marketing in only 1 or 4 "customer segments" so far.
Global Physician partnership signed with PhysioAge.
Telehealth partnership with Heartbeat Health signed.
Relaunch of the Cardiex website.
FDA submissions for Pulse & Conneqt Bank progressing well.
We should now get some regular good news from CDX - as the Pulse units arrive & start to be sold.
Should be an extremely exciting 12 months ahead - especially as our market cap is now less than $20m.
Add to My Watchlist
What is My Watchlist?
